NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)

NCT00920621

CompletedPhase 3

Sponsor: Brigham and Women's Hospital

Conditions: Asthma

Interventions: Vitamin D 3 cholecalciferol, Vitamin D3

Countries: United States

Vitamin D supplementation given to pregnant women will prevent asthma in their offspring and children.

Eligibility overview

Sex: FEMALE

Age: 18 Years to 39 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Personal history of asthma, eczema, allergic rhinitis or a history of asthma, eczema, allergic rhinitis in the biological father of the child
* Gestational age between 10 and 18 weeks at the time of randomization
* Maternal age between 18 and 39 years
* Not a current smoker
* English or Spanish speaking
* Intent to participate for the full 4 years (through Pregnancy and then until the 3rd birthday of the child)

Exclusion Criteria:

* Not meeting inclusion criteria
* Gestational age greater than 18 weeks
* Presence of chronic medical conditions
* Taking vitamin D supplements containing more than 2000 IU/day of vitamin D3
* Multiple gestation pregnancy (twins, triplets)
* Pregnancy achieved by assisted reproduction techniques (e.g., IUI, IVF)

Locations (3)

San Diego, California, United States
Boston, Massachusetts, United States
St Louis, Missouri, United States